Oliver Sexton
InvestorInvestment Director, Engineering Biology at UK Innovation & Science Seed Fund
London, England, United Kingdom
About
Oliver Sexton joined Midven in April 2014 to manage the UK Innovation & Science Seed Fund's engineering biology investments. He previously oversaw commercialisation of bioengineering and medical technologies at Imperial Innovations and served on the board of oncology company Acublate Ltd, with earlier commercial and partnering roles at Ark Therapeutics, biotech buy-side analysis, and pharma strategy consulting. He holds a BSc in Molecular Biology/Biotechnology and an MSc in Plant Science from Bristol University.
Invests in
BiotechDeep Tech
Experience
- Future Planet CapitalIC membercurrent2014 — present
- Future Planet CapitalInvestment Directorcurrent2014 — present
- CamGene TherapeuticsBoard Membercurrent2025 — present
- Ternary TherapeuticsBoard observercurrent2026 — presentLondon Area, United Kingdom
- HutanBioBoard Observercurrent2024 — present
- ikarovecDirectorcurrent2019 — present
- AntiverseBoard Observercurrent2021 — present
- twigBoard Observercurrent2022 — present
- Pencil Biosciences LimitedBoard Observercurrent2022 — present
- UK Innovation & Science Seed FundInvestment Directorcurrent2014 — presentLondon
- TropicInvestorcurrent2017 — present
- SOLASTA BioBoard Observercurrent2021 — present
- Imperial InnovationsHead Bio Engineering2010 — 2014
Skills & more
ExitsBoard of DirectorsMergers & Acquisitions (M&A)Investment AnalysisInvestment ComplianceFundraisingLicensingBoard DevelopmentBrand DevelopmentInvestmentsBiotechnologyVenture Capital
+7 more
LifesciencesCommercializationBusiness StrategyBiopharmaceuticalsStart-upsManagementPharmaceutical Industry- FCA Investment Manager — Financial Conduct Authority
From Oliver's professional profile.
Investments
Board seats
Acublate Ltd
Per the firm's website.
Colleagues at UK Innovation & Science Seed Fund
Alexander Leigh
Investment Director Defence & Security at UK Innovation & Science Seed Fund
Alison Campbell
Investor at UK Innovation & Science Seed Fund
Andrew Muir
Investment Director at UK Innovation & Science Seed Fund
Betty Bonnardel
Investor at UK Innovation & Science Seed Fund
Dr Colin Story
Investor at UK Innovation & Science Seed Fund
Dr Peter Hamley
Investor at UK Innovation & Science Seed Fund
Eddie Alleyn
Investor at UK Innovation & Science Seed Fund
Hassan Mahmudul
Investment Manager at Future Planet Capital
Frequently asked questions
- Who is Oliver Sexton?
- Oliver Sexton joined Midven in April 2014 to manage the UK Innovation & Science Seed Fund's engineering biology investments. He previously oversaw commercialisation of bioengineering and medical technologies at Imperial Innovations and served on the board of oncology company Acublate Ltd, with earlier commercial and partnering roles at Ark Therapeutics, biotech buy-side analysis, and pharma strategy consulting. He holds a BSc in Molecular Biology/Biotechnology and an MSc in Plant Science from Bristol University.
- Where does Oliver Sexton work?
- Oliver Sexton is Investment Director, Engineering Biology at UK Innovation & Science Seed Fund.
- What does Oliver Sexton invest in?
- Oliver Sexton invests in Biotech, Deep Tech.
- What boards does Oliver Sexton sit on?
- Oliver Sexton holds tracked board seats at Acublate Ltd.
- Where did Oliver Sexton go to school?
- Oliver Sexton studied at University of Bristol (Molecular Biology); University of Nottingham (PhD: Bioremediation).
Same school
Also attended University of Bristol243
Chris BischoffInvestment Team at General CatalystSaran DaviesInvestor at Moonfire VenturesThomas RubensInvestor at DN CapitalIgnacio García LeónEntrepreneur in Residence at FJ LabsAnnabel StoddartOffice Manager and Executive Assistant at Medical Excellence CapitalMichael PatersonCo-Founder & former CTO of Beamery
+ 237 more
Also attended University of Nottingham206
Catherine BergersenSenior Executive Assistant at Mayfair Equity PartnersRichard LeeInvestor at MedicxiMillan SuriPrincipal at Episode1Kieran RafterPrincipal at Marlin Equity PartnersTim SchmidtVice President, Fund Finance at Northpond VenturesRohan OzaCo-Founder & Managing Partner at CAVU Consumer Partners
+ 200 more




















.jpg)

















